RALEIGH, N.C., Oct. 30, 2013 /PRNewswire/ -- PRA, a leading clinical research organization, today announces that 22 employees have been named finalists in the 2013 Clinical Researcher of the Year competition. Fourteen employees represent PRA in the U.S. competition and eight employees represent PRA in the International competition.
The prestigious competition, organized by PharmaTimes, named PRA "Clinical Company of the Year" in 2012 based on the total points earned by its employees' performances in individual competitions. Last year, PRA staff members achieved two first-place prizes and two third-place prizes
PRA finalists in the 2013 U.S. competition for the "New CRA" category are Lee Steen, Maria Joshi, and Mercy Baker; the "Experienced CRA" category finalists are Jennifer Wiley and Susan Goodnough; the "Project Manager" category finalists are Promise Lawrence, Adrienne Stoudenmire, Sarah Connell, and Adam Cohen; and the "Team" category finalists are Denise Butler, Laura Hampshire, Dani Eaton, Denise Richard, and Heidi Miller.
PRA finalists in the International competition for the "Clinical Team" category are Alison Edwards, Clare Jeffery, Charlotte Craggs, and Angharad Smith; the "CRA" category finalist is Victoria Hawkins; the "CTA" category finalist is Ketaki Pathare; and the "Team Leader" category finalists are Emma Lewis and Justin Harvey.
The finals for the U.S. competition will take place Nov. 7, 2013, in Cary, N.C., at the global headquarters of SAS, a competition partner. An awards ceremony announcing the winners will take place later that day at the Umstead Hotel on the SAS campus.
The finals for the International competition will take place Nov. 13 and Nov. 28, 2013. An awards ceremony announcing the winners will take place Jan. 30, 2014, at 8 Northumberland Avenue, London.
One of the world's largest CROs, PRA is transforming clinical trials through our people, innovation and operational transparency. Our 10,000+ employees operate in more than 80 countries, delivering a broad spectrum of full-service and Embedded clinical trial solutions that meet the demands of a diverse marketplace.
Over the last 30+ years, PRA has established a reputation for specialized expertise and success in a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. Our forward-thinking approach to clinical research innovation, customized recruitment strategies and technological advances continues to make a difference to healthcare patients around the world.
To learn more about PRA, please visit praintl.com, email firstname.lastname@example.org.